EXACT Therapeutics AS EXTX.OL Stock
EXACT Therapeutics AS Price Chart
EXACT Therapeutics AS EXTX.OL Financial and Trading Overview
| EXACT Therapeutics AS stock price | 6 NOK |
| Previous Close | 12 NOK |
| Open | 11.7 NOK |
| Bid | 11 NOK x N/A |
| Ask | 12 NOK x N/A |
| Day's Range | 11.7 - 12 NOK |
| 52 Week Range | 10.1 - 19.8 NOK |
| Volume | 1.2K NOK |
| Avg. Volume | 301 NOK |
| Market Cap | 359.97M NOK |
| Beta (5Y Monthly) | 0.359799 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2 NOK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EXTX.OL Valuation Measures
| Enterprise Value | 292.26M NOK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 791.9791 |
| Price/Book (mrq) | 5.529954 |
| Enterprise Value/Revenue | 643.021 |
| Enterprise Value/EBITDA | -7.437 |
Trading Information
EXACT Therapeutics AS Stock Price History
| Beta (5Y Monthly) | 0.359799 |
| 52-Week Change | -35.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 19.8 NOK |
| 52 Week Low | 10.1 NOK |
| 50-Day Moving Average | 12.74 NOK |
| 200-Day Moving Average | 14.31 NOK |
EXTX.OL Share Statistics
| Avg. Volume (3 month) | 301 NOK |
| Avg. Daily Volume (10-Days) | 278 NOK |
| Shares Outstanding | 30M |
| Float | 10.28M |
| Short Ratio | N/A |
| % Held by Insiders | 64.13% |
| % Held by Institutions | 26.24% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 250:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -8971.049% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.46% |
| Return on Equity (ttm) | -46.94% |
Income Statement
| Revenue (ttm) | 454.52K NOK |
| Revenue Per Share (ttm) | 0.02 NOK |
| Quarterly Revenue Growth (yoy) | 762.69% |
| Gross Profit (ttm) | N/A |
| EBITDA | -39296164 NOK |
| Net Income Avi to Common (ttm) | -40104396 NOK |
| Diluted EPS (ttm) | -1.34 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 69.39M NOK |
| Total Cash Per Share (mrq) | 2.31 NOK |
| Total Debt (mrq) | 1.69M NOK |
| Total Debt/Equity (mrq) | 2.59 NOK |
| Current Ratio (mrq) | 4.808 |
| Book Value Per Share (mrq) | 2.17 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33851944 NOK |
| Levered Free Cash Flow (ttm) | -19336298 NOK |
Profile of EXACT Therapeutics AS
| Country | Norway |
| State | N/A |
| City | Oslo |
| Address | Østre Aker vei 19 |
| ZIP | 0581 |
| Phone | N/A |
| Website | https://www.exact-tx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology, infectious diseases, and brain diseases. The company's ACT platform is under Phase I multi-center international clinical trial in patients with liver metastases secondary to colorectal/pancreatic cancer. EXACT Therapeutics AS has a collaboration with GE Healthcare to support the research of immunotherapy responses in solid tumors with ACT. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was incorporated in 2012 and is based in Oslo, Norway.
Q&A For EXACT Therapeutics AS Stock
What is a current EXTX.OL stock price?
EXACT Therapeutics AS EXTX.OL stock price today per share is 6 NOK.
How to purchase EXACT Therapeutics AS stock?
You can buy EXTX.OL shares on the Oslo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for EXACT Therapeutics AS?
The stock symbol or ticker of EXACT Therapeutics AS is EXTX.OL.
Which industry does the EXACT Therapeutics AS company belong to?
The EXACT Therapeutics AS industry is Biotechnology.
How many shares does EXACT Therapeutics AS have in circulation?
The max supply of EXACT Therapeutics AS shares is 32.05M.
What is EXACT Therapeutics AS Price to Earnings Ratio (PE Ratio)?
EXACT Therapeutics AS PE Ratio is now.
What was EXACT Therapeutics AS earnings per share over the trailing 12 months (TTM)?
EXACT Therapeutics AS EPS is -1.2 NOK over the trailing 12 months.
Which sector does the EXACT Therapeutics AS company belong to?
The EXACT Therapeutics AS sector is Healthcare.